What is the appropriate management for a patient with urticaria on the neck, conjunctival erythema, and oral itching?

Immediate Management: Assess for Anaphylaxis and Treat with Antihistamines

This presentation of urticaria (hives) on the neck with red eyes and oral itching raises concern for a systemic allergic reaction that requires immediate assessment for anaphylaxis, followed by treatment with second-generation H1-antihistamines as first-line therapy.

Critical First Step: Rule Out Anaphylaxis

The combination of urticaria with oral itching (mucosal involvement) and conjunctival erythema suggests potential progression beyond simple urticaria. Immediately assess for:

• Respiratory symptoms: Throat tightness, difficulty swallowing, wheezing, stridor
• Cardiovascular compromise: Hypotension, tachycardia, dizziness
• Severe laryngeal angioedema: Voice changes, difficulty breathing

If any of these are present, this is anaphylaxis requiring intramuscular epinephrine 0.5 mL of 1:1000 (500 µg) immediately 1. The oral itching is particularly concerning as it may herald oropharyngeal angioedema.

If No Anaphylaxis: Standard Urticaria Management

First-Line Treatment

Start a second-generation non-sedating H1-antihistamine immediately 2, 1:

• Cetirizine (has shortest time to maximum concentration, advantageous when rapid effect needed) 1
• Alternatives: Loratadine, desloratadine, fexofenadine, or levocetirizine 1
• Patients should be offered choice of at least two different antihistamines as individual responses vary 1

Dose Escalation Algorithm

If inadequate control after 2-4 weeks (or earlier if symptoms intolerable):

1. Increase the antihistamine dose up to 4-fold the standard dose 2, 1

   • This is safe and recommended practice despite being above manufacturer's licensed dose 1
   • Example: Cetirizine 10 mg can be increased to 40 mg daily

2. If still inadequate control after up to 4-fold dosing:

   • Add omalizumab 300 mg every 4 weeks (second-line) 2
   • Can updose to 600 mg every 2 weeks if insufficient response 2
   • Allow up to 6 months for response 2

3. If omalizumab fails:

   • Consider cyclosporine up to 5 mg/kg body weight (third-line) 2
   • Requires monitoring of blood pressure and renal function every 6 weeks 2

Additional Considerations for Acute Presentation

Optional H2-antihistamine addition: Adding an H2-antihistamine (ranitidine or cimetidine) to the H1-antihistamine may provide better control than H1 alone, though this is off-label 1. For severe acute urticaria with IV access, the combination of diphenhydramine 50 mg IV plus ranitidine 50 mg IV has shown efficacy 3.

Short-course corticosteroids: While oral prednisolone 50 mg daily for 3 days may shorten duration of acute urticaria 1, recent evidence shows that adding corticosteroids to antihistamines does not consistently improve outcomes compared to antihistamines alone 3. Use corticosteroids judiciously and only for severe acute presentations, not routinely.

Trigger Avoidance

Counsel patient to avoid common aggravating factors 1:

• NSAIDs and aspirin (can worsen urticaria)
• Hot showers and overheating
• Tight clothing and skin scrubbing
• Alcohol
• Stress

Common Pitfalls

• Do not delay epinephrine if there is any concern for anaphylaxis—oral itching with urticaria is a red flag
• Do not use long-term corticosteroids for chronic urticaria management 1
• Do not continue ineffective standard-dose antihistamines for weeks—updose or escalate therapy promptly 2
• Do not use first-generation sedating antihistamines as monotherapy due to impaired concentration and performance 1